CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-25 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Sale | −24,100 | $30.38 | $732K | 11,223 |
| 2026-06-25 | Krasney Karen EVP, GENERAL COUNSEL | Sale | −24,100 | $30.38 | $732K | 30,547 |
| 2026-06-24 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Sale | −400 | $30.00 | $12K | 11,223 |
| 2026-06-24 | Krasney Karen EVP, GENERAL COUNSEL | Sale | −400 | $30.00 | $12K | 30,547 |
| 2026-06-22 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Sale | −500 | $30.00 | $15K | 11,223 |
| 2026-06-22 | Krasney Karen EVP, GENERAL COUNSEL | Sale | −500 | $30.00 | $15K | 30,547 |
| 2026-05-01 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −25,000 | $31.70 | $793K | 8,223 |
| 2026-05-01 | Krasney Karen EVP, GENERAL COUNSEL | Sale 10b5-1 | −25,000 | $31.70 | $793K | 30,547 |
| 2026-04-02 | Sabar Karimah Es Director | Sale 10b5-1 | −7,529 | $32.00 | $241K | 0 |
| 2026-04-01 | Sabar Karimah Es Director | Sale 10b5-1 | −53,735 | $31.03 | $1.7M | 0 |
| 2026-03-31 | Sabar Karimah Es Director | Sale 10b5-1 | −61,265 | $30.17 | $1.8M | 0 |
| 2026-03-31 | Bergmann Anthony CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −25,000 | $30.13 | $753K | 8,223 |
| 2026-03-31 | Krasney Karen EVP, GENERAL COUNSEL | Sale 10b5-1 | −25,000 | $30.12 | $753K | 30,547 |
| 2023-04-17 | Avat Xavier Former CBO | Sale | −14,772 | $64,258.00 | $949.2M | 0 |
| 2023-03-28 | Avat Xavier FORMER CHIEF BUSINESS OFFICER | Sale | −3,000 | $4.06 | $12K | 0 |
| 2022-06-29 | Musket David B Director | Sale | −28,215 | $3.77 | $106K | 12,747 |
| 2022-06-27 | Musket David B Director | Sale | −17,775 | $4.44 | $79K | 40,962 |
Page 1 of 1 · 17 trades